These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15161877)

  • 1. Widespread statin use recommended for patients with type 2 diabetes.
    Voelker R
    JAMA; 2004 May; 291(20):2419-20. PubMed ID: 15161877
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin power.
    Diabetes Forecast; 2008 Apr; 61(4):28. PubMed ID: 18478640
    [No Abstract]   [Full Text] [Related]  

  • 3. Statin treatment of patients with diabetes.
    Eisenbarth GS
    Curr Diab Rep; 2005 Apr; 5(2):83. PubMed ID: 15794908
    [No Abstract]   [Full Text] [Related]  

  • 4. New statin guidelines: do they apply to you?
    Harv Health Lett; 2014 Feb; 39(4):8. PubMed ID: 24669404
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular therapies and their role in diabetic eye disease.
    Denniston AK; Banerjee S; Gibson JM; Dodson PM
    Diabet Med; 2005 May; 22(5):665-6. PubMed ID: 15842530
    [No Abstract]   [Full Text] [Related]  

  • 6. Reviewing statin therapy in diabetes--towards the best practise.
    Matikainen N; Kahri J; Taskinen MR
    Prim Care Diabetes; 2010 Apr; 4(1):9-15. PubMed ID: 20171948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 8. Should all diabetic patients be treated with a statin?
    Kamari Y; Bitzur R; Cohen H; Shaish A; Harats D
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S378-83. PubMed ID: 19875585
    [No Abstract]   [Full Text] [Related]  

  • 9. Statins and diabetes.
    Hitman GA
    Diabet Med; 2014 Jun; 31(6):639. PubMed ID: 24835891
    [No Abstract]   [Full Text] [Related]  

  • 10. How can we prevent cardiovascular disease in diabetes.
    Wiklund O; Håversen L; Pettersson C; Hultén LM
    J Intern Med; 2007 Aug; 262(2):199-207. PubMed ID: 17645587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: a French adaptation of CARDS.
    Lafuma A; Colin X; Solesse A
    Arch Cardiovasc Dis; 2008 May; 101(5):327-32. PubMed ID: 18656091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and lipid lowering: where are we?
    Reckless JP
    BMJ; 2006 May; 332(7550):1103-4. PubMed ID: 16690643
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes and cardiovascular disease.
    Neil A
    Diabetes Obes Metab; 2003 Nov; 5 Suppl 1():S11-8. PubMed ID: 14984017
    [No Abstract]   [Full Text] [Related]  

  • 14. Should you put all diabetic patients on statins?
    Leiter LA
    J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis.
    Chen YH; Feng B; Chen ZW
    Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):116-20. PubMed ID: 22187291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins are diabetogenic--myth or reality?
    Sattar N; Taskinen MR
    Atheroscler Suppl; 2012 Aug; 13(1):1-10. PubMed ID: 22818818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New American College of Cardiology and American Heart Association cholesterol treatment guidelines: subjects with Type 2 diabetes are under treated with high-intensity statins.
    Tripolt NJ; Sourij H
    Diabet Med; 2014 Jul; 31(7):879-80. PubMed ID: 24612178
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular disease and lipids in diabetes.
    Garber AJ
    Med Clin North Am; 1998 Jul; 82(4):931-48. PubMed ID: 9706127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing cardiovascular disease risk in type 2 diabetes: is the focus on glycaemia warranted?
    Ferguson LD; Sattar N
    Diabetes Obes Metab; 2013 May; 15(5):387-91. PubMed ID: 23020636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Meggison H
    Clin Evid; 2004 Jun; (11):777-806. PubMed ID: 15652037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.